in ,

Vir, GSK plan to seek emergency use nod for COVID-19 antibody therapy (

GlaxoSmithKline’s Vir-7831 treatment has been so successful that scientists have stopped the study early. The UK-based firm is seeking emergency use authorisation in the US.

How too much mindfulness can spike anxiety (

How the pandemic could finally democratize commutes (